411
Atrium Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
623
FY23:
0.86
FY24:
0.48
FY25:
273
(positive)
Change from FY21 to FY25
millions USD
FY21:
16.4
FY22:
15.9
FY23:
9.44
FY24:
6.70
FY25:
5.51
Total assets
Change from FY21 to FY25
millions USD
FY21:
428
FY22:
639
FY23:
10.3
FY24:
7.19
FY25:
278
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
29.7
FY22:
51.9
FY23:
33.8
FY24:
26.8
FY25:
41.8
(negative)
Change from FY21 to FY25
millions USD
FY21:
16.5
FY22:
8.82
FY23:
47.1
FY24:
41.5
FY25:
29.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
381
FY22:
578
FY23:
−70.6
FY24:
−61.1
FY25:
207
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
428
FY22:
639
FY23:
10.3
FY24:
7.19
FY25:
278
All amounts in millions USD